Drug details
Prochieve (progesterone gel for vaginal use only)
type of Vaginal Preparations, Other, Progestins
Prochieve (progesterone gel) is a bioadhesive vaginal gel containing micronized progesterone, a female hormone, 8% indicated for progesterone supplementation or replacement as part of an Assisted Reproductive Technology ("ART") treatment for infertile women with progesterone deficiency and Prochieve 4% is indicated for the treatment of secondary amenorrhea. Prochieve 8% is indicated for use in women who have failed to respond to treatment with Prochieve 4%.
This drug may have the following side effects:
- headache
- nausea
- diarrhea
- fatigue,
- vomiting
- dizziness
- constipation
- abdominal pain
- depression
- muscle pain,
- back pain,
- drowsiness
- joint pain
- decreased sex drive
- increased appetite,
- mood swings,
- nervousness
- cramps
- upper respiratory tract infection.
- bloating
-
breast pain
or enlargement -
yeast infection -
vaginal discharge - genital itching
- pain around the anus,
- painful sexual intercourse,
- increased night-time urination,
- sleep problems, and